Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    2024 Episode 12 – Heart Failure, Chronic Kidney Disease, and Type 2 Diabetes

    2024 Episode 12 – Heart Failure, Chronic Kidney Disease, and Type 2 Diabetes

    FromKnow Diabetes by Heart™ Professional Education Podcast Series

    Start listeningView podcast show

    2024 Episode 12 – Heart Failure, Chronic Kidney Disease, and Type 2 Diabetes

    FromKnow Diabetes by Heart™ Professional Education Podcast Series

    ratings:
    Length:
    29 minutes
    Released:
    Mar 25, 2024
    Format:
    Podcast episode

    Description

    Listen to Katherine R. Tuttle, MD, FASN, FACP, FNKF, Anthony Good, DNP, MBA, FNP-BC, GNP-BC, and Joshua J. Neumiller, PharmD, CDCES, FASCP, FADCES discuss the prevalence of heart failure, chronic kidney disease, type 2 diabetes, and the impact these conditions have on patient outcomes. Management options to mitigate these risks, current guidelines and diagnostic practices will also be discussed.
    Released:
    Mar 25, 2024
    Format:
    Podcast episode

    Titles in the series (32)

    The American Heart Association and the American Diabetes Association are excited to announce a new podcast series for healthcare professionals. Know Diabetes by Heart™ Professional Education Podcast Series focuses on the link between cardiovascular disease (CVD) and type 2 diabetes (T2D). The series will consist of relevant cutting-edge topics such as up-to-date standards of care, guidelines and their implications for T2D and CVD, and approaches to shared decision making—among others. The American Heart Association’s and the American Diabetes Association's Know Diabetes by Heart Professional Education™ Podcast Series is brought to you by founding sponsors, Boehringer Ingelheim and Eli Lilly and Company Diabetes Alliance and Novo Nordisk, and national sponsors, Sanofi, AstraZeneca, and Bayer.